BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

by · The Cerbat Gem

BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the recipient of a significant drop in short interest in the month of July. As of July 31st, there was short interest totaling 1,000 shares, a drop of 99.2% from the July 15th total of 132,765 shares. Based on an average trading volume of 484 shares, the short-interest ratio is presently 2.1 days. Currently, 0.0% of the company’s stock are sold short.

BioNxt Solutions Price Performance

Shares of OTCMKTS:BNXTF traded up $0.01 during trading on Tuesday, reaching $0.23. 200 shares of the stock were exchanged, compared to its average volume of 222. BioNxt Solutions has a 1-year low of $0.14 and a 1-year high of $0.80. The stock has a fifty day moving average of $0.25 and a two-hundred day moving average of $0.34.

BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last announced its quarterly earnings results on Friday, May 29th. The company reported ($0.01) EPS for the quarter.

BioNxt Solutions Company Profile

(Get Free Report)

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.

See Also